Connect with us
  • Elysium


NR Headlines: Thursday 20th June

Welcome to your daily round-up of everything happening in the world of neurorehab. 



Welcome to your daily round-up of everything happening in the world of neurorehab. 


Depression during pregnancy or after birth linked to higher risk of cardiovascular disease

Women diagnosed with perinatal depression are more likely to develop cardiovascular disease in the following 20 years compared to women who have given birth without experiencing perinatal depression, according to research published in the European Heart Journal. The study is the first of its kind to look at cardiovascular health after perinatal depression and included data on around 600,000 women. It found the strongest links with risks of high blood pressure, ischemic heart disease and heart failure.


Existing high blood pressure drugs may prevent epilepsy

A class of drugs already on the market to lower blood pressure appears to reduce adults’ risk of developing epilepsy, Stanford Medicine researchers and their colleagues have discovered. The finding comes out of an analysis of the medical records of more than 2 million Americans taking blood pressure medications.

The study, published in JAMA Neurology, suggests that the drugs, called angiotensin receptor blockers, could prevent epilepsy in people at highest risk of the disease, including older adults who have had strokes.


Sound stimulation with precise timings helps understand brain wave functions

Using sound to stimulate certain brain waves has the potential to help those with dementia or cognitive decline sleep better, reveals a new study. Sleep disturbances are a common feature in dementia and may affect up to half of people living with the condition.

During the study, the research team from the University of Surrey and the UK Dementia Research Institute Centre for Care Research & Technology at Imperial College London, used sound stimulation to target alpha rhythms, a type of brainwave, at precise timings of the wave to investigate how the brain responds.


Brain recording device receives FDA clinical trial approval 

The FDA approved a clinical trial to test the effectiveness of an electronic grid that records brain activity during surgery, developed by engineers at the University of California San Diego.

The device with nanoscale sensors records electrical signals directly from the surface of the human brain in record-breaking detail. The grid’s breakthrough resolution could provide better guidance for planning and performing surgeries to remove brain tumors and treat drug-resistant epilepsy.

National Academies publishes roadmap for making ALS liveable 

The ALS Association has commended the National Academies for a groundbreaking new report on amyotrophic lateral sclerosis (ALS). The report, the result of an 18-month study, provides a comprehensive road map aimed at making ALS a livable disease within a decade. This significant milestone was driven by ALS advocates and the ALS Association, including securing $1 million in Congressional funding for the study.


Empowering primary care providers with data-driven cognitive screening tools increases identification of cognitive impairment

A new study finds that the SAGE test, a screening tool which has resulted in a significant increase in the detection of cognitive concerns, was easily incorporated into primary care providers’ visits. The discovery is crucial as primary care providers (PCPs) are typically the first to identify and evaluate patients with neurocognitive disorders such as Mild Cognitive Impairment (MCI), Alzheimer’s and dementia. 

However, the diagnosis of cognitive impairment has historically been challenging to establish in primary care settings due to lack of expertise to conduct robust cognitive measures, cost, and difficulties to incorporate these measures into time-limited PCP visits, cited by PCPs in a survey.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *